文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Internalisation and Biological Activity of Nucleic Acids Delivering Cell-Penetrating Peptide Nanoparticles Is Controlled by the Biomolecular Corona.

作者信息

Lorents Annely, Maloverjan Maria, Padari Kärt, Pooga Margus

机构信息

Institute of Molecular and Cell Biology, University of Tartu, 50411 Tartu, Estonia.

Institute of Technology, University of Tartu, 50411 Tartu, Estonia.

出版信息

Pharmaceuticals (Basel). 2021 Jul 12;14(7):667. doi: 10.3390/ph14070667.


DOI:10.3390/ph14070667
PMID:34358093
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8308718/
Abstract

Nucleic acid molecules can be transferred into cells to alter gene expression and, thus, alleviate certain pathological conditions. Cell-penetrating peptides (CPPs) are vectors that can be used for transfecting nucleic acids as well as many other compounds. CPPs associate nucleic acids non-covalently, forming stable nanoparticles and providing efficient transfection of cells in vitro. However, in vivo, expected efficiency is achieved only in rare cases. One of the reasons for this discrepancy is the formation of protein corona around nanoparticles, once they are exposed to a biological environment, e.g., blood stream. In this study, we compared protein corona of CPP-nucleic acid nanoparticles formed in the presence of bovine, murine and human serum. We used Western blot and mass-spectrometry to identify the major constituents of protein corona forming around nanoparticles, showing that proteins involved in transport, haemostasis and complement system are its major components. We investigated physical features of nanoparticles and measured their biological efficiency in splice-correction assay. We showed that protein corona constituents might alter the fate of nanoparticles in vivo, e.g., by subjecting them to phagocytosis. We demonstrated that composition of protein corona of nanoparticles is species-specific that leads to dissimilar transfection efficiency and should be considered while developing delivery systems for nucleic acids.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2432/8308718/4942bb85ccc5/pharmaceuticals-14-00667-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2432/8308718/9d5833cd76eb/pharmaceuticals-14-00667-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2432/8308718/17c0555918f3/pharmaceuticals-14-00667-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2432/8308718/af0cd55fb4a7/pharmaceuticals-14-00667-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2432/8308718/3988436689f7/pharmaceuticals-14-00667-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2432/8308718/7391f729e85b/pharmaceuticals-14-00667-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2432/8308718/e14c4d04dcf9/pharmaceuticals-14-00667-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2432/8308718/198b6731ba54/pharmaceuticals-14-00667-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2432/8308718/4942bb85ccc5/pharmaceuticals-14-00667-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2432/8308718/9d5833cd76eb/pharmaceuticals-14-00667-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2432/8308718/17c0555918f3/pharmaceuticals-14-00667-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2432/8308718/af0cd55fb4a7/pharmaceuticals-14-00667-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2432/8308718/3988436689f7/pharmaceuticals-14-00667-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2432/8308718/7391f729e85b/pharmaceuticals-14-00667-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2432/8308718/e14c4d04dcf9/pharmaceuticals-14-00667-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2432/8308718/198b6731ba54/pharmaceuticals-14-00667-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2432/8308718/4942bb85ccc5/pharmaceuticals-14-00667-g006.jpg

相似文献

[1]
Internalisation and Biological Activity of Nucleic Acids Delivering Cell-Penetrating Peptide Nanoparticles Is Controlled by the Biomolecular Corona.

Pharmaceuticals (Basel). 2021-7-12

[2]
Divalent Metal Ions Boost Effect of Nucleic Acids Delivered by Cell-Penetrating Peptides.

Cells. 2022-2-21

[3]
Recent developments in peptide-based nucleic acid delivery.

Int J Mol Sci. 2008-6

[4]
The Biomolecular Corona of Lipid Nanoparticles for Gene Therapy.

Bioconjug Chem. 2020-9-16

[5]
Peptide vectors for the nonviral delivery of nucleic acids.

Acc Chem Res. 2012-3-28

[6]
Cell penetration: scope and limitations by the application of cell-penetrating peptides.

J Pept Sci. 2014-10

[7]
Intracellular Delivery of Molecular Cargo Using Cell-Penetrating Peptides and the Combination Strategies.

Int J Mol Sci. 2015-8-18

[8]
Characteristics of Cell-Penetrating Peptide/Nucleic Acid Nanoparticles.

Mol Pharm. 2016-1-4

[9]
PepFects and NickFects for the Intracellular Delivery of Nucleic Acids.

Methods Mol Biol. 2015

[10]
Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.

Acc Chem Res. 2021-1-19

引用本文的文献

[1]
and Evaluation of the Pathology and Safety Aspects of Three- and Four-Way Junction RNA Nanoparticles.

Mol Pharm. 2024-2-5

[2]
The Impact of Serum Protein Adsorption on PEGylated NT3-BDNF Nanoparticles-Distribution, Protein Release, and Cytotoxicity in a Human Retinal Pigmented Epithelial Cell Model.

Pharmaceutics. 2023-8-30

[3]
Stabilizing Polymer Coatings Alter the Protein Corona of DNA Origami and Can Be Engineered to Bias the Cellular Uptake.

ACS Polym Au. 2023-6-7

[4]
Divalent Metal Ions Boost Effect of Nucleic Acids Delivered by Cell-Penetrating Peptides.

Cells. 2022-2-21

[5]
New Applications of Lipid and Polymer-Based Nanoparticles for Nucleic Acids Delivery.

Pharmaceutics. 2021-12-1

本文引用的文献

[1]
NickFect type of cell-penetrating peptides present enhanced efficiency for microRNA-146a delivery into dendritic cells and during skin inflammation.

Biomaterials. 2020-12

[2]
The Biomolecular Corona of Lipid Nanoparticles for Gene Therapy.

Bioconjug Chem. 2020-9-16

[3]
Deciphering the internalization mechanism of WRAP:siRNA nanoparticles.

Biochim Biophys Acta Biomembr. 2020-3-2

[4]
Interactions at the cell membrane and pathways of internalization of nano-sized materials for nanomedicine.

Beilstein J Nanotechnol. 2020-2-14

[5]
RNA-Based Therapeutics: From Antisense Oligonucleotides to miRNAs.

Cells. 2020-1-7

[6]
Sugar and Polymer Excipients Enhance Uptake and Splice-Switching Activity of Peptide-Dendrimer/Lipid/Oligonucleotide Formulations.

Pharmaceutics. 2019-12-9

[7]
The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs.

Nat Nanotechnol. 2019-12

[8]
Cell penetrating peptides: the potent multi-cargo intracellular carriers.

Expert Opin Drug Deliv. 2019-10-15

[9]
Enhancement of siRNA transfection by the optimization of fatty acid length and histidine content in the CPP.

Biomater Sci. 2019-9-24

[10]
Chemical Development of Therapeutic Oligonucleotides.

Methods Mol Biol. 2019

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索